ArticleFrontiers in neurology2026
Blood pressure variability and parenchymal hematoma after endovascular thrombectomy: effect modification by recanalization status and cerebral small vessel disease burden.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We investigated the association between post-thrombectomy blood pressure variability (BPV) and parenchymal hematoma (PH), and whether this relationship is modified by persistent vessel patency and cerebral small vessel disease (CSVD) burden. Methods: We analyzed 302 patients with acute ischemic stroke who underwent endovascular thrombectomy. PH was defined as confluent hemorrhage with a mass effect. BPV was assessed using 2-h blood pressure measurements during the first 24 h. Parameters included the maximum, minimum, mean, range, standard deviation, coefficient of variation, and successive variation of systolic, diastolic, and pulse pressure (PP). CSVD burden was quantified using the total CSVD score and dichotomized into none-to-mild (score 0-1) and moderate-to-severe (score 2-4). Multivariable logistic regression models were used to evaluate associations and interaction effects. Results: PH occurred in 78 patients (25.8%). Among BPV parameters, pulse pressure successive variation (PP Conclusion: Increased post-thrombectomy BPV, particularly PP variability, was independently associated with PH, with effects modified by persistent vessel patency and CSVD burden. These findings suggest individualized blood pressure management based on macrovascular persistent vessel patency and underlying microvascular integrity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.